Utility of the 21-month neurodevelopmental outcome for predicting neurodevelopmental impairment at 36 months for preterm infants <29 weeks gestation.

Doucette, Stefani M; Tang, Selphee; Kehler, Heather; Creighton, Dianne; Lodha, Abhay

Doucette, Stefani M; Tang, Selphee; Kehler, Heather; Creighton, Dianne; Lodha, Abhay.

Affiliation

Doucette SM; Division of Neonatology, Department of Pediatrics, Foothills Medical Centre, University of Calgary, Calgary, Alberta, Canada.
Tang S; Alberta Health Services, Calgary, Alberta, Canada.
Kehler H; Neonatal Follow-Up Clinic, Department of Pediatrics, Alberta Children's Hospital, University of Calgary, Calgary, Alberta, Canada.
Creighton D; Alberta Health Services, Calgary, Alberta, Canada.
Lodha A; Neonatal Follow-Up Clinic, Department of Pediatrics, Alberta Children's Hospital, University of Calgary, Calgary, Alberta, Canada.

J Perinatol ; 43(11): 1406-1412, 2023 11.

Article in En | MEDLINE | ID: mdl-37714894

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Infant, Premature / Neurodevelopmental Disorders Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Child / Female / Humans / Infant / Newborn / Pregnancy Language: En Journal: J Perinatol Journal subject: PERINATOLOGIA Year: 2023 Document type: Article Affiliation country: Canadá

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google